NKGN
NKGen Biotech, Inc. Common Stock
NKGN
NKGN
Delisted
NKGN was delisted on the 4th of March, 2025.
17 hedge funds and large institutions have $4.24M invested in NKGen Biotech, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.
Holders
17
Holders Change
+4
Holders Change %
+30.77%
% of All Funds
0.25%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
6
Increased
4
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
DC
1
Diametric Capital
Boston,
Massachusetts
|
$423K |
2 |
2
UBS Group
Zurich,
Switzerland
|
$55.6K |
3 |
VF
3
Virtu Financial
New York
|
$24K |
4 |
4
BlackRock
New York
|
$21.5K |
5 |
5
Geode Capital Management
Boston,
Massachusetts
|
$86.9K |